大疱性类天疱疮-话题@MedSci

#大疱性类天疱疮#

19篇内容 | 1414人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1775165, encodeId=fbde1e751655c, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=Front Immunol：使用格列汀降低大疱性类天疱疮和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗体, objectType=article, longId=739441, objectId=f6efe39441ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6efe39441ca, replyNumber=0, likeNumber=116, createdTime=2023-06-15, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6efe39441ca, moduleTitle=Front Immunol：使用格列汀降低大疱性类天疱疮和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6efe39441ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775164, encodeId=a2d51e7516407, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=JAMA Dermatol：Nomacopan治疗大疱性类天疱疮老年患者的耐受性良好，疗效佳, objectType=article, longId=732192, objectId=fe13e321925b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe13e321925b, replyNumber=0, likeNumber=85, createdTime=2022-07-16, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe13e321925b, moduleTitle=JAMA Dermatol：Nomacopan治疗大疱性类天疱疮老年患者的耐受性良好，疗效佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe13e321925b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2105178, encodeId=642921051e81b, content=使用<a href='/topic/show?id=35ce1050e686' target=_blank style='color:#2F92EE;'>#格列汀类#</a>降低<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>和<a href='/topic/show?id=d20f1090c2' target=_blank style='color:#2F92EE;'>#2型糖尿病#</a>患者的<a href='/topic/show?id=3b941608085' target=_blank style='color:#2F92EE;'>#SDF-1#</a>/<a href='/topic/show?id=8342553e7b' target=_blank style='color:#2F92EE;'>#CXCL12#</a>水平，但不增加<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>抗<a href='/topic/show?id=3a54363e13' target=_blank style='color:#2F92EE;'>#BP180#</a>的<a href='/topic/show?id=39998636197' target=_blank style='color:#2F92EE;'>#自身抗体#</a>水平。<a href='/topic/show?id=2c679051240' target=_blank style='color:#2F92EE;'>#西格列汀#</a>，这项研究有意思, objectTitle=Front Immunol：使用格列汀降低大疱性类天疱疮和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗体, objectType=article, longId=739441, objectId=f6efe39441ca, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/114.jpg, objectUrl=/article/show_article.do?id=f6efe39441ca, replyNumber=0, likeNumber=162, createdTime=2022-12-10, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f6efe39441ca, moduleTitle=Front Immunol：使用格列汀降低大疱性类天疱疮和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6efe39441ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775163, encodeId=3d621e75163a0, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=Front Immunol：大疱性类天疱疮的IL-13遗传易感性：治疗的潜在目标和预后标志物, objectType=article, longId=295764, objectId=5ef2295e6419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ef2295e6419, replyNumber=0, likeNumber=80, createdTime=2022-08-08, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ef2295e6419, moduleTitle=Front Immunol：大疱性类天疱疮的IL-13遗传易感性：治疗的潜在目标和预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ef2295e6419)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775162, encodeId=494f1e751621c, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=BJD:大疱性类天疱疮和寻常型天疱疮患者的病因特异性死亡率研究, objectType=article, longId=294997, objectId=b13929499ebf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b13929499ebf, replyNumber=0, likeNumber=91, createdTime=2022-02-16, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b13929499ebf, moduleTitle=BJD:大疱性类天疱疮和寻常型天疱疮患者的病因特异性死亡率研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b13929499ebf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775161, encodeId=15011e7516104, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=JEADV：第一针新冠肺炎疫苗可能引发天疱疮和大疱性类天疱疮：因此第二针是禁忌吗？, objectType=article, longId=294988, objectId=d239294988ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d239294988ee, replyNumber=0, likeNumber=86, createdTime=2022-10-07, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d239294988ee, moduleTitle=JEADV：第一针新冠肺炎疫苗可能引发天疱疮和大疱性类天疱疮：因此第二针是禁忌吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d239294988ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775160, encodeId=3a491e75160bf, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=J Invest Dermatol：抑制糖代谢可缓解获得性大疱性类天疱疮样表皮松解症, objectType=article, longId=207467, objectId=9f5120e46784, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f5120e46784, replyNumber=0, likeNumber=81, createdTime=2021-03-10, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f5120e46784, moduleTitle=J Invest Dermatol：抑制糖代谢可缓解获得性大疱性类天疱疮样表皮松解症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f5120e46784)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775159, encodeId=2c641e7515904, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=美国FDA授予Nomacopan治疗大疱性类天疱疮的孤儿药物指定, objectType=article, longId=179480, objectId=a6c61e94804e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6c61e94804e, replyNumber=0, likeNumber=90, createdTime=2020-07-28, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6c61e94804e, moduleTitle=美国FDA授予Nomacopan治疗大疱性类天疱疮的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6c61e94804e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775157, encodeId=2a7e1e751574f, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=JAMA Dermatol：大疱性类天疱疮黏膜受累的患病率评估, objectType=article, longId=165070, objectId=a32f1650e0ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a32f1650e0ce, replyNumber=0, likeNumber=104, createdTime=2020-02-13, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a32f1650e0ce, moduleTitle=JAMA Dermatol：大疱性类天疱疮黏膜受累的患病率评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a32f1650e0ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775158, encodeId=17101e751583b, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=Diabetes Care：2型糖尿病患者服用二肽基肽酶-4抑制剂与大疱性类天疱疮风险, objectType=article, longId=168207, objectId=3bd316820e59, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bd316820e59, replyNumber=0, likeNumber=75, createdTime=2019-07-26, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bd316820e59, moduleTitle=Diabetes Care：2型糖尿病患者服用二肽基肽酶-4抑制剂与大疱性类天疱疮风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bd316820e59)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775155, encodeId=7eb61e75155ba, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=行医笔记：一文掌握大疱性类天疱疮, objectType=article, longId=120289, objectId=dffd120289f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dffd120289f7, replyNumber=0, likeNumber=105, createdTime=2018-04-30, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dffd120289f7, moduleTitle=行医笔记：一文掌握大疱性类天疱疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dffd120289f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775154, encodeId=998c1e75154bf, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=Health Technol Assess：大疱性类天疱疮：多西环素PK泼尼松龙, objectType=article, longId=105152, objectId=ee9d1051524f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee9d1051524f, replyNumber=0, likeNumber=74, createdTime=2018-01-30, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee9d1051524f, moduleTitle=Health Technol Assess：大疱性类天疱疮：多西环素PK泼尼松龙, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee9d1051524f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775156, encodeId=fc7c1e7515609, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=银屑病合并大疱性类天疱疮继发卡波西肉瘤一例, objectType=article, longId=128569, objectId=affd128569e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=affd128569e9, replyNumber=0, likeNumber=94, createdTime=2018-10-19, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=affd128569e9, moduleTitle=银屑病合并大疱性类天疱疮继发卡波西肉瘤一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=affd128569e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775153, encodeId=3b581e75153f7, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=SCI REP：嗜酸性粒细胞阳离子蛋白是大疱性类天疱疮患者的严重程度和预后的预测指标！, objectType=article, longId=104848, objectId=79ed104848ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79ed104848ee, replyNumber=0, likeNumber=86, createdTime=2017-11-22, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79ed104848ee, moduleTitle=SCI REP：嗜酸性粒细胞阳离子蛋白是大疱性类天疱疮患者的严重程度和预后的预测指标！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79ed104848ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775152, encodeId=edad1e7515230, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=Lancet：大疱性类天疱疮——多西环素vs泼尼松龙初始治疗策略, objectType=article, longId=99526, objectId=b11e99526a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b11e99526a0, replyNumber=0, likeNumber=90, createdTime=2017-08-07, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b11e99526a0, moduleTitle=Lancet：大疱性类天疱疮——多西环素vs泼尼松龙初始治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b11e99526a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775149, encodeId=fb151e751499d, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=大疱性类天疱疮诊断和治疗的专家建议, objectType=article, longId=77769, objectId=084ae7769c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=084ae7769c4, replyNumber=0, likeNumber=91, createdTime=2017-02-16, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=084ae7769c4, moduleTitle=大疱性类天疱疮诊断和治疗的专家建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=084ae7769c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775151, encodeId=a0981e751519e, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=Lancet：多西环素与泼尼松龙治疗大疱性类天疱疮哪个更优？, objectType=article, longId=91661, objectId=1c6a91661bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c6a91661bc, replyNumber=0, likeNumber=80, createdTime=2017-08-06, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c6a91661bc, moduleTitle=Lancet：多西环素与泼尼松龙治疗大疱性类天疱疮哪个更优？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c6a91661bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775148, encodeId=eb271e75148e2, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=2016大疱性类天疱疮诊断和治疗的专家建议发布, objectType=article, longId=74755, objectId=7cfde4755cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cfde4755cf, replyNumber=0, likeNumber=51, createdTime=2016-09-25, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cfde4755cf, moduleTitle=2016大疱性类天疱疮诊断和治疗的专家建议发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cfde4755cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1775150, encodeId=d0e31e751508d, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, objectTitle=JAMA Dermatol：大疱性类天疱疮的血清抗体研究, objectType=article, longId=82213, objectId=b83182213b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b83182213b6, replyNumber=0, likeNumber=74, createdTime=2017-10-16, rootId=0, userName=freve, userId=dc0e38759441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b83182213b6, moduleTitle=JAMA Dermatol：大疱性类天疱疮的血清抗体研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b83182213b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

大疱性类天疱疮

2020-05-29

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

Front Immunol：使用格列汀降低大疱性类天疱疮和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗体

2023-06-15

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

JAMA Dermatol：Nomacopan治疗大疱性类天疱疮老年患者的耐受性良好，疗效佳

2022-07-16

lifestar (审核中...)

前往app查看评论内容

使用#格列汀类#降低#大疱性类天疱疮#和#2型糖尿病#患者的#SDF-1#/#CXCL12#水平，但不增加#糖尿病患者#抗#BP180#的#自身抗体#水平。#西格列汀#，这项研究有意思

Front Immunol：使用格列汀降低大疱性类天疱疮和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗体

2022-12-10发表于上海

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

Front Immunol：大疱性类天疱疮的IL-13遗传易感性：治疗的潜在目标和预后标志物

2022-08-08

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

BJD:大疱性类天疱疮和寻常型天疱疮患者的病因特异性死亡率研究

2022-02-16

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

JEADV：第一针新冠肺炎疫苗可能引发天疱疮和大疱性类天疱疮：因此第二针是禁忌吗？

2022-10-07

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

J Invest Dermatol：抑制糖代谢可缓解获得性大疱性类天疱疮样表皮松解症

2021-03-10

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

美国FDA授予Nomacopan治疗大疱性类天疱疮的孤儿药物指定

2020-07-28

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

JAMA Dermatol：大疱性类天疱疮黏膜受累的患病率评估

2020-02-13

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

Diabetes Care：2型糖尿病患者服用二肽基肽酶-4抑制剂与大疱性类天疱疮风险

2019-07-26

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

行医笔记：一文掌握大疱性类天疱疮

2018-04-30

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

Health Technol Assess：大疱性类天疱疮：多西环素PK泼尼松龙

2018-01-30

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

银屑病合并大疱性类天疱疮继发卡波西肉瘤一例

2018-10-19

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

SCI REP：嗜酸性粒细胞阳离子蛋白是大疱性类天疱疮患者的严重程度和预后的预测指标！

2017-11-22

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

Lancet：大疱性类天疱疮——多西环素vs泼尼松龙初始治疗策略

2017-08-07

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

大疱性类天疱疮诊断和治疗的专家建议

2017-02-16

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

Lancet：多西环素与泼尼松龙治疗大疱性类天疱疮哪个更优？

2017-08-06

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

2016大疱性类天疱疮诊断和治疗的专家建议发布

2016-09-25

freve (审核中...)

前往app查看评论内容

#大疱性类天疱疮#

JAMA Dermatol：大疱性类天疱疮的血清抗体研究

2017-10-16

科室
- - 订阅+
  - 更多科室
工具
服务